AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Andrea Pfeifer, PhD$242.3M
Market Cap • 17/04/20242003
(há 21 anos)
2016
(8 years ago)
NASDAQ
Listagem
Lausanne
156
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ACIUSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.